COVID-19 — Coronavirus

Status
Not open for further replies.
Spring in the step news this.
Incredible really given we're in the same year a new virus entered (and wrought havoc) on the world.

The issue now will be wording of the roll out.
I wish those anti-ant-vaxxers wouldn't be so aggressive with their language, but this happens on both sides of the political debates...never a good starting point to call people cunts all the time if they don't agree with you.
Change of opinion happens rather more subtly.
 
Yes the press conference was good but there weren’t many facts. It was enough info for what I need but sceptics might want to see the published research results.
 
So there’s no understanding yet of whether the Pfizer vaccine actually stops people from spreading the virus? We know it’s effective at preventing symptoms, but does it also stop transmission? Hancock certainly seemed to suggest they don’t know yet and will monitor it as it’s rolled out. Were there no indications during the trials?
 
How long does the immunity last?

That isn’t known yet mate

It will be years and years.

Antibodies might not last a year, but the B and T cells which make the antibodies and actually kill the virus last for a long, long time, decades usually.

It might mean you get an incredibly mild version as your immune system spins up and churns out antibodies, but as far as it being a fatal disease, you'll be fine for ages.
 
So there’s no understanding yet of whether the Pfizer vaccine actually stops people from spreading the virus? We know it’s effective at preventing symptoms, but does it also stop transmission? Hancock certainly seemed to suggest they don’t know yet and will monitor it as it’s rolled out. Were there no indications during the trials?
It will be good to know some info on this, but I’m also thinking that providing the vast majority get vaccinated then it might not matter too much in the grand scheme of things?
 
So there’s no understanding yet of whether the Pfizer vaccine actually stops people from spreading the virus? We know it’s effective at preventing symptoms, but does it also stop transmission? Hancock certainly seemed to suggest they don’t know yet and will monitor it as it’s rolled out. Were there no indications during the trials?

You can't really test that in a clinical trial - only a hundred or so people caught the virus on the control arm, so those no happening on the active arm is a drop in the ocean of overall community infectivity.

I think the plan is is monitor population transmission as more people are vaccinated. And the Oxford trial included regular PCR testing, so that will give clues.
 
You can't really test that in a clinical trial - only a hundred or so people caught the virus on the control arm, so those no happening on the active arm is a drop in the ocean of overall community infectivity.

I think the plan is is monitor population transmission as more people are vaccinated. And the Oxford trial included regular PCR testing, so that will give clues.
Cheers mate
 
I think there will be a lot of refusal to take the vaccine, quite a large percentage in fact.
I will be having one but there seems to be a lot of people who won't have it. It seems a bit coincidental to me that the day after lockdown finishes that the vaccine is approved, I can't but think it's too soon.
Let's hope for the best however.
 
Germans talking about Biontechs vaccine on Sky News. Very different time from the UK launch of Pfizer they opened up with the potential side effects and their temporary symptoms.
 
So Prof Sarah Gilbert at Oxford has explained that the half dosage wasn’t an error but planned process to look at the impact of varying the first dosage, that she says is common practice in research trials.

It appears to be that there has been inconsistencies in the media treatment of the Oxford / AZ research compared to other vaccine candidates. That said, Oxford should have been better prepared to explain their research findings and the small numbers of over 55s in their sample. Anyway, it will be down to the regulators to approve the Oxford / AZ vaccine candidate or not.
 
So Prof Sarah Gilbert at Oxford has explained that the half dosage wasn’t an error but planned process to look at the impact of varying the first dosage, that she says is common practice in research trials.

It appears to be that there has been inconsistencies in the media treatment of the Oxford / AZ research compared to other vaccine candidates. That said, Oxford should have been better prepared to explain their research findings and the small numbers of over 55s in their sample. Anyway, it will be down to the regulators to approve the Oxford / AZ vaccine candidate or not.

I blame Cambridge.
 
I think there will be a lot of refusal to take the vaccine, quite a large percentage in fact.
I will be having one but there seems to be a lot of people who won't have it. It seems a bit coincidental to me that the day after lockdown finishes that the vaccine is approved, I can't but think it's too soon.
Let's hope for the best however
The take-up rate from those who are at risk will be very high. The only concern at the moment should be the logistical challenge of getting the at-risk vaccinated given that many may not be very mobile and this vaccine needs to be stored carefully.
 
Status
Not open for further replies.

Don't have an account? Register now and see fewer ads!

SIGN UP
Back
Top